Financial Performance
5Y price score: 43
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 33%
US$ Per
Share
By default your notes are visible only to you.
58.5
52-week range
108.9
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
5.4 %
Dividend Yield TTM
2.5 %
Market cap $
$ 137,124
Price / Earnings TTM
47.3
Price / Book TTM
1.8
PEG TTM
(0.8)
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
74 %
46.1 %
33 %
Free cash flow per share growth
22.5 %
(39.9) %
12.1 %
Earnings per share growth
(62) %
(74.5) %
(70) %
Founded: 1,863
Employees: 219,000
Business Summary:
Latest Earnings Call Takeaways
2026 Q1 (May 7, 2026)
1) Strategy & Leadership - CVS Health is focused on improving healthcare access and affordability, aiming to become America's most trusted healthcare company. - The company is enhancing relationships with stakeholders to address key priorities and improve healthcare for Americans. - CVS is committed to value-based care and is actively engaging with CMS and regulators to drive changes in the healthcare ecosystem. - The launch of Health100, an AI-driven consumer engagement platform, is set for later this year, aimed at integrating various healthcare stakeholders and improving consumer experiences.
2) Financial & Segment Results - CVS reported Q1 2026 adjusted operating income of $5.2 billion and adjusted EPS of $2.57, reflecting a 14% YoY increase. - Total revenue exceeded $100 billion, up 6% YoY, driven by growth across all segments. - The Health Care Benefits segment generated nearly $36 billion in revenue, with an adjusted operating income of approximately $3 billion and a medical benefit ratio of 84.6%. - The Health Services segment saw revenues of over $48 billion, an 11% YoY increase, though adjusted operating income decreased by 7% due to pharmacy client price improvements. - The Pharmacy & Consumer Wellness segment maintained revenues of nearly $32 billion, with same-store pharmacy sales growing over 3%.
3) Problems / Headwinds - The Medicare Advantage program faces challenges due to underlying medical cost trends that remain above historical levels, impacting margins. - CVS is navigating regulatory changes, including PBM legislation, which could affect pricing and reimbursement structures. - The company is addressing the impact of recent generic drug introductions and reimbursement pressures on pharmacy operations.
4) Operational or Product Plans - CVS is focused on reducing friction in healthcare processes, particularly in prior authorization, with Aetna leading the industry in minimizing such requirements. - The company plans to exclude branded STELARA from formularies in favor of biosimilars, aiming for significant patient conversion rates. - Investments in technology and AI are central to CVS's strategy, with ongoing efforts to enhance consumer engagement and operational efficiency.
5) Guidance & Outlook / Investor Angle - CVS has raised its full-year 2026 adjusted EPS guidance to a range of $7.30 to $7.50, reflecting confidence in continued performance. - The company expects total revenues to reach at least $405 billion and cash flow from operations of at least $9.5 billion. - CVS is optimistic about achieving target margins in Medicare Advantage by 2028, despite current challenges.
Bottom line: CVS Health's strong Q1 performance and revised guidance reflect effective execution of its strategic priorities, positioning the company for continued growth and improved healthcare outcomes, making it an attractive proposition for shareholders.
Annual Reports, Presentations And IR Contacts
Go to the websiteCVS Health Corporation — Financial Overview, Stock Price, Market Cap
CVS Health Corporation is a company. Founded in 1863. As of July 20, 2026, the company's market capitalization is $137124197100 with a current stock price of $107.47.